BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21299374)

  • 1. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
    Kiraz N; Oz Y; Dag I
    Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
    Krishnan S; Manavathu EK; Chandrasekar PH
    J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
    Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
    J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
    Oz Y; Dag I; Kiraz N
    Mycopathologia; 2012 Jan; 173(1):27-34. PubMed ID: 21842180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
    van de Sande WW; Tavakol M; van Vianen W; Bakker-Woudenberg IA
    Med Mycol; 2010 Feb; 48(1):48-55. PubMed ID: 20055743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
    Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
    Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
    Liu W; Li L; Sun Y; Chen W; Wan Z; Li R; Liu W
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6414-6. PubMed ID: 23027186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
    Yekutiel A; Shalit I; Shadkchan Y; Osherov N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
    J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro.
    Natesan SK; Chandrasekar PH; Alangaden GJ; Manavathu EK
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):369-73. PubMed ID: 18061388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
    Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE; Wiederhold NP; Klepser ME
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
    Elefanti A; Mouton JW; Verweij PE; Tsakris A; Zerva L; Meletiadis J
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4656-63. PubMed ID: 23856768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.